Abstract: The present disclosure relates to pharmaceutical compositions comprising Compound I, or a pharmaceutically acceptable salt thereof, as the active substance. The pharmaceutical compositions are suitable for use in immediate release pharmaceutical formulations. The pharmaceutical formulations are suitable for use in the treatment of medical conditions in which treatment with agonists of CB1/CB2 receptors are beneficial.
Type:
Application
Filed:
July 12, 2021
Publication date:
January 25, 2024
Applicant:
ARTELO BIOSCIENCES LIMITED
Inventors:
Andrew YATES, Paul DICKINSON, Robert WARD